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Abstract: Fucoidan, the sulfated fucose-rich polysaccharide derived from brown macroalgae,
was reported to display some anti-cancer effects in in vitro and in vivo models that included
apoptosis and cell cycle arrest. The proposed mechanisms of action involve enhanced immune
surveillance and direct pro-apoptotic effects via the activation of cell signaling pathways that remain
largely uncharacterized. This study aimed to identify cellular pathways influenced by fucoidan
using an unbiased genetic approach to generate additional insights into the anti-cancer effects of
fucoidan. Drug–gene interactions of Undaria pinnatifida fucoidan were assessed by a systematic
screen of the entire set of 4,733 halpoid Saccharomyces cerevsiae gene deletion strains. Some of the
findings were confirmed using cell cycle analysis and DNA damage detection in non-immortalized
human dermal fibroblasts and colon cancer cells. The yeast deletion library screen and subsequent
pathway and interactome analysis identified global effects of fucoidan on a wide range of eukaryotic
cellular processes, including RNA metabolism, protein synthesis, sorting, targeting and transport,
carbohydrate metabolism, mitochondrial maintenance, cell cycle regulation, and DNA damage
repair-related pathways. Fucoidan also reduced clonogenic survival, induced DNA damage and
G1-arrest in colon cancer cells, while these effects were not observed in non-immortalized human
fibroblasts. Our results demonstrate global effects of fucoidan in diverse cellular processes in
eukaryotic cells and further our understanding about the inhibitory effect of Undaria pinnatifida
fucoidan on the growth of human cancer cells.
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1. Introduction
Fucoidans are a class of fucose rich sulfated polysaccharides derived from brown macroalgae that
are associated with a large range of bioactivities [1,2]. As a naturally occurring part of edible seaweed,
it is already part of the normal diet in many countries. Therefore, certain fucoidan extracts have
obtained ‘generally recognized as safe’ (GRAS) status in the US and received novel foods approval
in the EU. Fucoidans have long been noted as a selectin blocking compound that inhibits cell–cell
interactions [3]. This ability to disrupt cell–cell interactions is likely at least in part, responsible
for the potent anti-inflammatory activity of different fucoidan preparations [1]. Fucoidans can also
inhibit the adhesion of proteins and organisms to non-biological surfaces, and may help to inhibit
biofouling [4]. The anti-microbial activity of fucoidans is also largely based on its inhibition of
Mar. Drugs 2019, 17, 54; doi:10.3390/md17010054 www.mdpi.com/journal/marinedrugs
Mar. Drugs 2019, 17, 54 2 of 15
bacteria-substrate binding [5]. However, in a C. elegans infection model, a fucoidan extract increased
the immunity of the host organism and downregulated quorum sensing genes in the bacterial
pathogen, which suggests that fucoidans also have the potential to impact gene expression and
cellular signaling pathways [6]. While fucoidan-mediated effects on yeasts and fungi are largely
unexplored, different fucoidan preparations have also been investigated for their anti-cancer activity
in vitro and in vivo [7,8]. In vivo, the anti-cancer response appears to be a combination of enhanced
immune function, regulation of checkpoint inhibitor levels [9,10], and a direct cytotoxic activity on
cancer cells such as DU-145 human prostate cancer cells [11]. In pre-clinical colon cancer cell models,
fucoidans induced both apoptosis and cell cycle arrest, while the exact mechanism for this effect
remains unclear [12–15]. One suggested mode of action involves fucoidan-induced endoplasmic
reticulum (ER) stress that induces apoptotic cancer cell death via the activation of unfolded protein
response (UPR) pathways [14,16,17]. Fucoidan treatment of HCT-116 colon cancer cells resulted
in downregulation of the ER protein 29 (ERp29), and activated the phosphorylation of eukaryotic
initiation factor 2 alpha (p-eIF2a)/CCAAT/enhancer binding protein homologous protein (CHOP)
pro-apoptotic cascade [14]. Surprisingly, another fucoidan preparation was also described to protect
against endoplasmic reticulum (ER) stress [18]. Autophagy, necessary for the bulk degradation of
cellular components is recognized as an important mechanism for cell survival under conditions of ER
stress. In this context, fucoidans are described as antagonists of scavenger receptors and may even
protect against or modulate autophagy in macrophages [18,19].
Despite a large degree of experimental consistency, the molecular differences in fucoidan
preparations significantly complicate the comparison of reported results. To obtain an unbiased view
of the multiple, sometimes conflicting, biological activities and signaling mechanisms that are affected
by fucoidans in proliferating cells, this study initially examined the effects of a well-defined fucoidan
extract from the edible macroalga Undaria pinnatifida by screening a S. cerevisiae gene deletion library.
This eukaryotic model and type of analysis has been used widely in genome-wide phenotypic screens
to understand cellular responses to environmental stressors and to deduce drug–gene interactions in
higher organisms [20–24]. For this purpose, the present study employed a single-gene deletion library
of S. cerevisiae strains and incubated the gene deletion strains in the absence and presence of fucoidan.
By comparing the overall growth (population density) of the gene deletion strains in the absence and
presence of fucoidan we were able to unearth genes, and hence potential genetic/functional pathways
impacted by fucoidan. This experimental approach enables a global view of drug–gene interactions
in the yeast system, which, due to a high degree of functional conservation, can also inform our
understanding of fucoidan-gene interactions in the mammalian system. We used this experimental
approach to address the question of how one type of edible fucoidan—from Undaria pinnatifida—exerts
its reported anti-cancer effects, and what, if any, effects it might have on normal healthy cells. Using
this approach for the first time, the present study identified a wide range of fucoidan-affected cellular
processes in yeast, some of which were subsequently confirmed in studies involving mammalian cells.
2. Results
2.1. Yeast Gene Deletion Library Results
To gain an unbiased insight into gene-fucoidan interactions, the growth of the complete library
of 4,733 haploid S. cerevisiae gene deletion strains was measured in the absence and presence of
500 g/mL Undaria pinnatifida fucoidan, UPF. Based on a cutoff value of 1.5-fold change in cell growth
at least 115 deletion strains showed reduced proliferation in the presence of fucoidan compared to
control (YPD alone grown) cultures (Table S1). Out of these, 82 genes (71%) were associated with
known cellular processes, while 33 genes (29%) were of unknown function. In contrast, 177 deletion
strains showed increased growth in the presence of UPF (Table S1). From these, 136 genes (77%) were
associated with well described cellular processes and 41 genes (23%) were of unknown function.
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Overall, the data indicated that UPF likely interacts with a wide range of genes whose protein are
potentially involved in distinct cellular processes, including DNA replication, maintenance and repair,
mRNA transcription and processing, ribosome biogenesis, amino acid biosynthesis, carbohydrate
and nucleotide metabolism, protein transport and degradation, organelle (mitochondria and vacuole)
transport and maintenance, general and oxidative stress responses, and a considerable number of
pathways whose precise identities in the eukaryotic/mammalian system remain to be fully determined.
To interrogate this dataset in more detail, pathway analysis using String software was employed
(Figure 1). In a first iteration, only the 115 genes were assessed whose absence reduced the growth of
S. cerevisiae in the presence of UPF by at least 1.5-fold (Figure 1A). Using a high confidence interaction
score of 0.9 (“highest confidence”), the software identified seven major functional groups that included
peroxisome biogenesis, amino acid biogenesis, cyclin-cAMP signaling, cell cycle control, DNA repair,
RNA polymerase complex, and energy metabolism (Figure 1A).
As a second step, only those genes were interrogated, whose absence increased the growth of S.
cerevisiae in the presence of UPF by at least 1.5-fold (Figure 1B). Using the same stringency settings of 0.9,
the software strongly predicted the involvement of the ribosome function and biogenesis, chromatin
remodeling and DNA repair, cell cycle checkpoints, mitochondrial stress response, transcription,
peroxisome biogenesis, and microtubule-DNA dynamics (Figure 1B).
In a final analysis, all 292 genes identified as being important for the growth of S. cerevisiae (by at
least 1.5-fold) in the presence of UPF were included together in the pathway analysis. This combined
analysis revealed some genetic/functional pathways that were not identified in the initial analysis
(Figure 1A,B), such as the effects of UPF on mitochondrial t-RNA synthase, nucleotide biosynthesis,
transcription elongation and splicing, as well as protein transport mechanisms. In addition, this form
of analysis strengthened previously identified pathway-UPF connections such as an effect on ribosome
function, mitochondrial and energy metabolism and DNA repair by adding more genes to previously
identified nodes (Figure 1C).
2.2. Mammalian Cell Studies
Based on the observed UPF-gene interactions in S. cerevisiae, a UPF-induced cellular stress response
was postulated that included cell cycle checkpoints and DNA damage repair pathways. This study
intended to translate the genetic pathways identified in yeast to a mammalian system. Since we did
not aim to study anti-cancer activity of UPF in general, only one well characterized cell line was used
exemplary instead of a range of cancer cell lines. To confirm the presence of UPF-induced cell cycle
control and DNA damage in mammalian cells the general level of toxicity of UPF was assessed in
HCT-116 colorectal cancer cells.
2.2.1. Viability Assessment Using WST-1
The WST-1 cell proliferation assay is frequently used as a measure of cell proliferation or
cytotoxicity. It is based on the metabolic production of NAD(P)H, which is used as a surrogate
marker for cell death, cytostatic activity or metabolic inhibition by test compounds [25]. To assess
short-term effects of fucoidan treatment, log-phase HCT-116 colon cancer cells were exposed to UPF
over 24 h before WST-1 conversion was measured (Figure 2). Surprisingly, the presence of UPF at
concentrations of up to 100 µg/mL showed no signs of toxicity to the colon cancer cells in the WST-1
assay, regardless of serum concentration in the cell culture media. In fact, low UPF concentrations
of up to 2.5 µM appeared to significantly increase WST-1 dye conversion (Figure 2). This effect
likely represents an artefact of the redox-active nature of the UPF preparation as described for other
compounds [26], which required us to assess cellular viability in the presence of UPF by other assays.
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Figure 1. (A) Pathway analysis of identified genes that resulted in reduced growth of S. cerevisiae in 
the presence of UPF. Pathway analysis was performed with String software (Version 10.5) using an 
interaction score of 0.9 (‘highest confidence’). The figure only shows connected genes with 
disconnected nodes hidden. (B) Pathway analysis of identified genes that resulted in increased 
growth of S. cerevisiae in the presence of UPF. Pathway analysis was performed with String software 
(Version 10.5) using an interaction score of 0.9 (‘highest confidence’). The figure only shows connected 
genes with disconnected nodes hidden. (C) Pathway analysis of all identified genes that interacted 
with UPF. Pathway analysis was performed with String software (Version 10.5) using an interaction 
score of 0.9 (‘highest confidence’). The figure only shows connected genes with disconnected nodes 
hidden. 
Figure 1. (A) Pathway analysis of identified genes that resulted in reduced growth of S. cerevisiae in
the presence of UPF. Pathway analysis was performed with String software (Version 10.5) using an
interaction score of 0.9 (‘hig est confidence’). The figure only shows connected genes with disconnected
nodes hidden. (B) Pathway analysis of identified genes that resulted i increased growth of S. cerevisiae
in the presence of UPF. Pathway analysis was performed with String software (Version 10.5) using an
interaction score of 0.9 (‘highest confidence’). The figure only shows connected genes with disconnected
nodes hidden. (C) Pathway analysis of all identified genes that interacted with UPF. Pathway analysis
was performed with String software (Version 10.5) using an interaction score of 0.9 (‘highest confidence’).
The figure only shows connected genes with disconnected nodes hidden.
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exposed to UPF concentrations of up to 100 µg/mL for 24 h before viability was assessed using WST-
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individual wells per experiment and are expressed as % viability compared to the untreated control 
cells. Error bars represent SD with *: p < 0.05. Hydrogen peroxide (H, 100 µM) was used as a positive 
control for toxicity. 
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treatment. Consistent with the WST-1 data, UPF showed hardly any effects on the number of colonies 
after two weeks of continuous treatment. Only the highest UPF concentration (100 µM) showed a 
significant (p < 0.05) reduction in colony numbers by about 25% under optimal cell culture conditions 
(Figure 3A). To assess this effect in more detail, the experiment was repeated but the serum 
concentration of the cell culture media was reduced to 2%. Since the colony formation assay is 
essentially measuring ‘proliferative fitness’ of cells in culture, the reduction of growth factors is a 
commonly used approach to increase the stringency of this assay to detect mild, non-lethal toxicities. 
While this reduced FCS content did not change the overall cloning efficiency of the cells in the absence 
of UPF (similar numbers of colonies in the untreated cultures at 2% and 10% FCS; data not shown), 
it had a dramatic effect on the activity of UPF. Even at the lowest UPF concentration, a highly 
significant (p < 0.001) drop in colony numbers of about 70% was observed (Figure 3A). This toxicity 
increased further in a dose dependent manner, where only 7% residual colonies were observed at the 
highest UPF concentration (Figure 3A). 
To assess if this toxicity was specific to immortalized cells or would also apply to other cell types, 
the effect of UPF was tested on the colony formation activity of non-immortalized primary human 
dermal fibroblasts (HDF). These cells are significantly more sensitive to their culture conditions and 
only form colonies with at least 10% fetal calf serum (FCS). Therefore, lower FCS concentrations could 
not be tested. In contrast to HCT-116 cells, UPF treatment of HDF cells led to a bell-shaped 
concentration curve with a significant increase in colony numbers between 10 and 50 µM. Even at the 
highest UPF concentration (100 µM), HDF still showed at least as many colonies as the untreated 
control cells (Figure 3B). 
Figure 2. Effect of UPF on metabolic activity/viability. Human colon carcinoma cells (HCT-116)
were exposed to UPF concentrations of up o 100 µg/mL for 24 h before viability was a sessed using
WST-1 reagent. Data represent one typical experiment out of up to four independent experiments.
WST-1 absorption data were standardized on prot in content for each well, r present th mea of six
individual wells per exp riment and are express d as % viability compared to th u treated co tr l
cells. Error bars represent SD with *: p < 0.05. Hydrogen peroxide (H, 100 µM) was used as a positive
control for toxicity.
2.2.2. Colony Formation Assay
In contrast to the WST-1 assay that only detects acute toxicity of a compound based on metabolic
activity, the colony formation assay was employed to also assess any long-term effects of UPF treatment.
Consistent with the WST-1 data, UPF showed hardly any effects on the number of colonies after two
weeks of continuous treatment. Only the highest UPF concentration (100 µM) showed a significant
(p < 0.05) reduction in colony numbers by about 25% under optimal cell culture conditions (Figure 3A).
To assess this effect in more detail, the experiment was repeated but the serum concentration of the
cell culture media was reduced to 2%. Since the colony formation assay is essentially measuring
‘proliferative fitness’ of cells in culture, the reduction of growth factors is a commonly used approach
to increase the stringency of this assay to detect mild, non-lethal toxicities. While this reduced FCS
content did not change the overall cloning efficiency of the cells in the absence of UPF (similar numbers
of colonies in the untreated cultures at 2% and 10% FCS; data not shown), it had a dramatic effect
on the activity of UPF. Even at the lowest UPF concentration, a highly significant (p < 0.001) drop
in colony numbers of about 70% was observed (Figure 3A). This toxicity increased further in a dose
dependent manner, where only 7% residual colonies were observed at the highest UPF concentration
(Figure 3A).
To assess if this toxicity was specific to immortalized cells or would also apply to other cell types,
the effect of UPF was tested on the colony formation activity of non-immortalized primary human
dermal fibroblasts (HDF). These cells are significantly more sensitive to their culture conditions and
only form colonies with at least 10% fetal calf serum (FCS). Therefore, lower FCS concentrations
could not be tested. In contrast to HCT-116 cells, UPF treatment of HDF cells led to a bell-shaped
concentration curve with a significant increase in colony numbers between 10 and 50 µM. Even at
the highest UPF concentration (100 µM), HDF still showed at least as many colonies as the untreated
control cells (Figure 3B).
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Figure 3. Effect of UPF on colony formation. Human colon carcinoma cells (HCT-116, A) and human
non-immortalized dermal fibroblasts (HDF, B) were exposed to UPF concentrations up to 100 µg/mL
in a colony formation assay. Data represent one typical experiment out of up to four independent
experiments. Data is expressed as the mean +/− SD of four plates and expressed as % colony formation
compared to the untreated control cells. Error bars represent SD with #: p < 0.05 and * p < 0.001.
2.2.3. Assessment of UPF-induced DNA Damage
The sp cific toxicity observed in the colorectal cancer cell line was consistent with the yeast data
that indicated an interaction between UPF and DNA repair pathways. The typical mode of action
of most anti-cancer agents is the induction of DNA damage. Nuclear γH2AX staining is a marker
of DNA damage-induced cellular repair activity and is frequently used as very sensitive marker for
the presence of DNA damage, especially DNA double strand breaks [27]. To assess if UFP induces
DNA damage, non-immortalized human skin fibroblasts (HDF) and colon cancer cells (HCT-116) were
exposed to 100 µg/mL UPF over 24 h. In untreated HDF, only about 10% of cells showed any γH2AX
foci at all and these cells displayed typically less than four foci. After exposure to UPF no increase in
the number of positive cells was evident and the positive cells also did not show increased numbers
of foci (Figure 4A,B) and those HDF with γH2AX foci had only very low numbers of foci (Figure 4B).
In contrast to HDF, close to 40% of HCT-116 cells showed γH2AX foci in the absence of UPF, indicative
of the genetic instability that is characteristic to many tumor cell lines. More importantly HCT-116
cells showed a very significant (p < 0.01) UPF-induced effect with nearly 90% of all cells positive for
γH2AX foci after 24 h (Figure 4A). In contrast to HDF, HCT-116 cells also showed very high numbers
of γH2AX foci per cell after exposure to UPF (Figure 4C).
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immunostaining was performed (A) Data represents the mean of 3 experiments and expressed as 
% γH2AX-positive cells. Error bars represent SD with *: p < 0.001. (B) Data represent one typical 
experiment out of three experiments for HDF. n/a: cells excluded from analysis due to unquantifiable 
staining pattern. (C) Representative images for UPF-induced induction of nuclear γH2AX foci in HCT-
116 cells. H2O2-treatment (100 µM, 30 min) was used as a positive control. Merged images represent 
software generated false color overlays of DAPI and γH2AX signals. 
2.2.4. Cell Cycle Assay by Fluorescence-activated Cell Sorting (FACS) 
To understand the long-term toxicity of UPF on HCT-116 cells in the colony formation assay, 
cell cycle analysis by flow cytometry was employed. UPF induced a significant (p < 0.01) G1 arrest at 
72 h, while all prior time points remained non-significant. The corresponding reduction in S-phase 
cells approached significance (p = 0.052), while no effects were observed with regards to the number 
of cells in G2 phase (Figure 5).  
Figure 4. DNA damage induction by u an colon carcinoma cells (HCT-116, A,C) and human
non-immortalized ermal fibroblasts ( , , ) r exposed to 100 µg/mL UPF before γH2AX
immunostaining was performed (A) Data represents the mean of 3 experiments and expressed as
% γH2AX-positive cells. Error bars represent SD with *: p < 0.001. (B) Data represent one typical
experiment out of three experiments for HDF. n/a: cells excluded from analysis due to unquantifiable
staining pattern. (C) Representative images for UPF-induced induction of nuclear γH2AX foci in
HCT-116 cells. H2O2-treatment (100 µM, 30 min) was used as a positive control. Merged images
represent software generated false color overlays of DAPI and γH2AX signals.
2.2.4. Cell Cycle Assay by Fluorescence-activated Cell Sorting (FACS)
To understand the long-term toxicity of UPF on HCT-116 cells in the colony formation assay,
cell cycle analysis by flow cytometry was employed. UPF induced a significant (p < 0.01) G1 arrest at
72 h, while all prior time points remained non-significant. The corresponding reductio in S-phase
cells approached significance (p = 0.052), while no effects were observed with regards to the number of
cells in G2 phase (Figure 5).
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3. Discussion
This study initially examined the gene-drug interactions of Undaria pinnatifida fucoidan (UPF)
by screening the complete S. cerevisiae gene deletion library to achieve an unbiased genome-wide
assessment of the eukaryotic genetic/functional pathways potentially affected by this fucoidan.
Especially in cases where (i) a test compound is associated with a multitude of biological effects,
or (ii) nothing is known about the biological effects of a test compound, or (iii) a gene of interest,
this approach has been used successfully [28]. The present study identified a large number of
interacting pathways affected by UPF that broadly affected cellular energy metabolism, RNA synthesis,
DNA synthesis and repair, cell cycle control, protein synthesis and transport. Our yeast data are
in general agreement with a previous report that employed microarray gene expression analysis of
Fucus vesiculosus extract treated pancreatic cells [29]. While that report also highlighted the effect of
fucoidan on DNA damage repair and cell cycle regulation, it did not identify the additional pathways,
such as ribosomal or mitochondrial involvement, that our analysis provided for UPF.
When the effects of UPF on cell cycle control predicted by the yeast results were subsequently
tested in a mammalian cell culture system, our results largely confirmed previous reports of G1 arrest.
Fucoidan isolated from Fucus vesiculosus was previously reported to induce a G1 arrest in the same cell
line used in the present study [13], while polysaccharides from peony seeds also induced a G1 arrest
in the same cell line [30]. However, in the present study UPF led to a much milder G1 arrest that only
occurred after 72 hours and with lower magnitude compared to the previous report where a significant
increase was already detected after 36 hours [13]. The extent of G1 arrest was much more comparable
to the second report, which observed a G1-arrest already after 24 hours, so it remains unclear how
many cells would have accumulated in G1 phase after 72 hours [30].
As a major difference to the previous studies [13,30], UPF did not induce any overt cytotoxicity
or signs of cell death. Previous studies reported polysaccharide-induced loss of membrane integrity,
reduced metabolism and apoptosis [13]. In the present study, a distinctive lack of UPF-induced cell
death or cytotoxicity was evident in the WST-1 and the colony formation assays when the cells were
grown under standard conditions. Only when cells were treated under conditions of reduced growth
factor availability did UPF reduce cellular metabolism. This somewhat hidden sensitivity supports
the yeast results that suggest that UPF interacts with cellular energy metabolism. Thus, the observed
UPF hypersensitivity under reduced growth factor signaling indicates a synergistic mode of action.
Surprisingly, UPF-induced cytotoxicity at the level of cell proliferation was only observed in the colon
cancer cell line but not in non-immortalized human dermal fibroblasts (HDF). Although, it has to
be acknowledged that toxicity in these cells could have been present at lower serum concentrations,
these cells do not form colonies under these conditions and in contrast to signs of toxicity our results
indicate a significant UPF-dependent increase in colony formation in HDF. This cell type specific
difference was not entirely unexpected, as previous reports highlighted that fucoidans can induce
proliferation in primary fibroblasts without inducing toxicity [31,32].
To explore the mild toxicity observed in the cancer cell line further, we investigated the possibility
of fucoidan-induced DNA damage. Although molecular signatures indicative of fucoidan-induced
DNA damage (such as Tunnel staining), have been reported earlier [14], low-molecular weight
fucoidan was conversely reported to inhibit DNA-damage induced signaling (including γH2AX
foci) in etoposide-treated HCT-116 cells [33]. Our results for the first time, indicate a direct and very
potent DNA damaging activity by UPF by itself that appears to be very selective for the cancer cell
line tested. In untreated HCT-116 cells, compared to fibroblasts, elevated basal levels of γH2AX
foci were detected, which reflects the reported genetic instability and hypermutator phenotype of
colorectal cancer cells [34]. Upon exposure to UPF, foci numbers in the cancer cell line increased
dramatically, to 90 foci/nucleus, which is among the highest numbers reported, while foci numbers in
the fibroblasts remained unaffected at a significantly lower level. This significant difference obviously
poses the question: how can UPF elicit this cell type specific response and how exactly does UPF
induce DNA damage?
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Although, the majority of the literature reports anti-oxidant activity of fucoidan, our WST-1
results indicate that UPF has some redox activity that, together with the appropriate metabolic
background could also act as a pro-oxidant. This double-edged redox activity has been reported for
many common antioxidants from vitamins C and E to CoenzymeQ10 [35]. There is also evidence
that the anti-cancer effects of fucoidans could be attributed to a pro-oxidant activity [36,37]. Whilst
UPF-induced production of reactive oxygen species (ROS) could well explain the rapid induction of
DNA damage observed in the present study, it is striking that despite this toxicity, cell cycle effects
only became evident after 72 hours. Even more surprising is the complete lack of detectable cell
death in the presence of extensive DNA damage. A different Undaria pinnatifida fucoidan extract
was previously reported to increase ROS production via a mitochondria-dependent mechanism in a
hepatocarcinoma cell line [38]. In contrast to the present study, this was associated with cytotoxicity
within 12–24 hours but with no effects on cell cycle within this time frame. However, previous reports
of fucoidan-induced cell death in cancer cells typically used significantly higher concentrations of
fucoidan compared to the present study [13,30,38]. We therefore cannot exclude that significantly
higher UPF concentrations would have also induced cell death in our experimental setting. Given
the uncertainty of achievable fucoidan concentrations in the cancer microenvironment in vivo, it is
relatively futile to interpret these cytotoxic dose-differences with regards to any therapeutic usefulness.
Nevertheless, a mitochondrial mode of action of UPF represents an intriguing possibility to explain
the cell type specific differences observed in the present study. Given that cancer cells use their
mitochondria in a manner very distinct to normal non-immortalized cells [39] future studies will have
to delineate the detailed mechanisms of how fucoidans can specifically alter mitochondrial function in
cancer cells to induce the cell type-specific effects observed in this and previous studies.
It has to be noted that one of the difficulties of comparative analysis is that fucoidan extracts
from different source algae, prepared by using different methods may contain impurities such as
polyphenolics, alginates, or other co-extracts. Since the concentrations used in many previous
experiments have been relatively high, it cannot be excluded that minor co-extracts rather than
the fucoidan itself could have affected the results. Therefore, the current study aimed to use
fucoidan with a well-characterized molecular composition and at concentrations low enough to
mimic potential physiologically achievable levels. This approach was chosen to enable comparative
baseline data for future investigations. In addition, this study used an unbiased approach to identify
Undaria pinnatifida fucoidan-gene interactions that were successfully translated to mammalian cell
responses, which validates the use of S. cerevisiae as an initial screening tool. Therefore, this approach
could be used in future studies to characterize and more importantly compare different fucoidan
preparations that differ in their extraction methods, geographic sources, and species origins. This
approach would enable cost effective and reliable comparisons of different extracts and their
associated bioactivities.
4. Materials and Methods
4.1. Materials
If not otherwise stated, all chemicals were obtained from Sigma-Aldrich (Castle Hill, NSW, Australia).
Undaria pinnatifida fucoidan (UPF) was obtained from Marinova (Cambridge, TAS, Australia). This material
was provided with a quoted fucoidan purity of 85.1% (dry weight). The calculation of fucoidan purity
requires several inputs that are determined using spectrophotometric assays. The total carbohydrate
content of a hydrolyzed sample was determined using the phenol-sulfuric method of Dubois [40,41],
while the uronic acid content was determined by spectrophotometric analysis of the hydrolyzed compound
in the presence of 3-phenylphenol, based on a method described by Filisetti-Cozzi and Carpita [41]. Sulfate
content was analyzed spectrophotometrically using a BaSO4 precipitation method (BaCl2 in gelatin), based
on the work of Dodgson [42], and found to be 24.6%. The molecular weight profile was determined via gel
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permeation chromatography using a size-exclusion column and reported relative to Dextran standards,
with peak molecular weight found at 47.7 kDa.
4.2. Yeast Gene Deletion Library
Briefly, a stock concentration (5 mg/mL) of UPF was prepared in YPD liquid medium (10 g yeast
extract, 20 g peptone, and 20 g dextrose / liter) and sterilized by filtration (cellulose acetate membrane,
0.45 mm pore size, Microscience, Taren Point NSW, Australia). Stock solutions were kept at 4 ◦C until
required. The wild-type (parental) Saccharomyces cerevisiae strain BY4741 (MATa his3∆1 leu2∆0 met15∆0
ura3∆0), along with its mutant derivatives covering ~96% of the yeast genome, were obtained from GE
Healthcare Dharmacon (Millennium Science, Mulgrave, VIC, Australia). The 4733 gene deletion strains
(representing the entire set of nonessential genes for this organism) were supplied frozen in a 96-well
microtitre plate format, with individual wells containing settled yeast cells in YPD liquid medium
supplemented with 200 µg/mL G418 and 12.5% glycerol. Sub-master plates (Thermo-Fisher Scientific,
North Ryde, NSW, Australia) were prepared by thawing the relevant master plate and transferring 10 µl
aliquots of each well to 96-well plates containing 90 mL of YPD liquid medium supplemented with
G418 (200 µg/mL). The plates were incubated for two days at 30 ◦C, before 12.5% glycerol was added
to each well and the plates stored at minus 80 ◦C. To prepare experimental 96-well plates containing
the deletion strains, the sub-master plates were thawed before a 10 µl aliquot of each well (containing
~1 × 106 cells) was transferred to 96-well plates containing either 90 mL YPD-alone, or 90 mL YPD+500
µg/mL UPF. The wild-type (parental) S. cerevisiae strain BY4741 was grown overnight at 30 ◦C in YPD
liquid medium to a density of ~1 × 108, before a 10 µl aliquot was inoculated in wells of a 96-well plate
containing either 90 mL YPD-alone, or else 90 mLYPD+500 µg/mL UPF. All plates were incubated at
30 ◦C, 5% CO2, for 24 h before the growth of the wild-type control and deletion strains was determined
by optical density (OD) at 600 nm using a Spectramax M2 microplate spectrophotometer (Molecular
Devices, San Jose, CA, USA). The sensitivity of each strain to the fucoidan treatment was determined
by comparing its growth (optical density) in the absence and presence of fucoidan. Gene deletion
strains showing a growth deficit of at least ~1.5 fold were scored as sensitive.
4.3. Pathway Analysis
Pathway analysis was performed using String software 10.5 (https://string-db.org) using largely
default settings with an interaction score of 0.9 and gene sets restricted to S. cerevisiae. Images were
generated by hiding disconnected nodes and only showing connected genes. Line thickness was used
to illustrate evidence. Settings for the maximum number of interactors to show were selected as first
shell: none (only query genes); second shell: none (only query genes). Images were exported from
String and pathways were annotated manually in PowerPoint.
4.4. Colony Formation Assay
UPF-containing media was filtered through 0.45 µm syringe top filters to generate stock solutions
of 1 mg/mL. Human colorectal carcinoma cells (HCT-116, 91091055) or non-immortalized human
dermal fibroblasts (HDF) (106-05A) were used. Single cell suspensions were seeded in culture media
(HCT-116: McCoy’s 5A, M4892) with 2 or 10% FBS, HDF: DMEM (D5523)with 2 or 10% FBS. HCT-116
cells were seeded at 2000 cells per 10 cm culture dish in 2% FCS or 360 cells in 4cm culture dish in
10% while, HDF were seeded at 300 cells per 10 cm culture dish in 10% FCS. After overnight adhesion,
the cells were exposed to fucoidan concentrations up to 100 µg/mL for two weeks without media
change. The assay was terminated by fixation with 2% w/v paraformaldehyde in PBS for 10–15 min at
RT. Colonies were then stained with 0.25% Coomassie Brilliant Blue in 50% (v/v) methanol, 10% (v/v)
acetic acid for 5 min at RT. Colonies consisting of more than 50 cells were counted by eye (HCT-116) or
under the microscope (HDF). Results are derived from at least four parallel replicates and presented as
% colony formation (compared to the untreated control cells).
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4.5. WST-1 Assay
This viability assay is based on the enzymatic cleavage of the tetrazolium salt WST-1 to formazan
by cellular dehydrogenases present in viable cells. The dye cannot permeate the cell membrane
and is reduced outside the cell via the plasma membrane electron transport system. HCT-116 cells
were seeded at a density of 5000 cells per well in 96-well plates in 100 µl of 2 or 10% FBS containing
McCoy’s media and allowed to adhere overnight. Cells were subsequently treated with various UPF
concentrations for 24 h to assess acute toxicity. After this time-period the media was removed and
100 µl of fresh media containing 5 µl of WST-1 reagent (Cayman, Sapphire Biosciences Redfern, NSW,
Australia) added in each well. Following a 2 h incubation at 37 ◦C the plate was read in a microplate
reader at 450 nm. The WST-1 data for each well were standardized on protein content and the results
expressed as % viability.
4.6. Detection of DNA Damage by γH2AX
To assess if UPF causes DNA damage, induction of nuclear γH2AX foci was quantified as
described previously [43]. Briefly, 1 × 105 HCT-166 or HDF cells were seeded on sterile coverslips
in 12 well plates. After adherence, cells were treated with 100 µg/mL fucoidan and incubated for
24 h. Cells were then fixed with 4% PFA in PBS for 15 min and lysed with 1 mL/well of B1 buffer
(10% FBS, 0.5% Triton X-100 and PBS) for 1 h at RT on a plate shaker at 200 rpm, followed by two
washes with 1 mL of the same buffer. Cells were then incubated with the anti-γH2AX antibody
(anti-phospho-histone H2A.X(Ser139), (clone JBW301, Lot 2476967, Merck, Bayswater, VIC, Australia)
in buffer B1 at 4 ◦C over night in a humidified chamber. Subsequently, the coverslips were washed
3 x 2 min with W1 buffer (5% FBS, 0.5% Triton X-100 and 0.5× PBS), followed by incubation with
species-specific secondary antibody (Alexa Fluor 488 (ab’) 2 fragment of goat anti-mouse IgG (H+L),
(ab150117, Abcam, Melbourne, VIC, Australia) for 1 h at RT in B1 buffer. After three washes with W1
buffer and one wash with 1 mL PBS/well, cells were incubated with DAPI (1:10,000) for 5 min to stain
the nuclei. After three more washes with 0.5 × PBS, auto-fluorescence was quenched by incubating
the cells with 1 mL of W2 buffer (5mM CuSO4 in 5 mM ammonium acetate buffer adjusted to pH 5)
/well for 20 min at RT. Coverslips were then mounted on microscope slides using Slow Fade Gold
anti-fade reagent (S36936, Thermo-Fisher Scientific, North Ryde, NSW, Australia) and stored in the
dark until used. Slides were then assessed by counting 3 x 100 cells per condition. The number of cells
that contained foci as well as how many foci per cell were present was assessed.
4.7. Cell Cycle Analysis
After incubation with 0.1 mg/mL UPF for up to 72h HCT-116 cells were harvested by
trypsinization and washed with Dulbecco’s phosphate buffered saline (DPBS). 1.5 × 106 cells were
resuspended in 750 µl of cold DPBS and left on ice for 10 min. 3 mL of 95% ethanol (−20 ◦C) were added
steadily to the cells, while gently vortexing, before the cells were further fixed for 30 min at 4 ◦C on ice.
Cells were then washed with DPBS twice by centrifuging for 5 min at 850 g. Supernatant was aspired
carefully before cells being resuspended in 450 µl of cold DPBS and counted to adjust cell density to
1 × 106 cells/mL. Cells were additionally treated with 5 µl of ribonuclease A (10 mg/mL) before DNA
was stained with 100 µl of propidium iodide (PI) (1 mg/ mL) and incubated light-protected at 37 ◦C for
15 min. Fluorescence was measured using an attune acoustic focusing cytometer (Applied Biosystems,
Thermo-Fisher Scientific, North Ryde, NSW, Australia). 10,000 events per sample were collected using
the accompanying attune acoustic focusing software. Changes in the percentage of cell distribution for
each phase of the cell cycle were used to determine cell cycle effects of Undaria pinnatifida fucoidan
compared to untreated control cells. Cell cycle data was analyzed using FLOWJO software (version 10,
Treestar, Ashland, Oregon, USA).
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5. Conclusions
Exposure of a S. cerevisiae deletion library to an Undaria pinnatifida fucoidan extract (UPF)
identified a total of 292 genes, whose products are potentially involved in the cellular response
to UPF. Pathway analysis grouped these genes into a large number of pathways and cellular functions
that included ribosome function and biogenesis, cell cycle signaling and DNA repair, nucleotide and
amino acid biosynthesis, peroxisomal biosynthesis, mitochondrial function and energy metabolism,
RNA synthesis, protein synthesis, and transport. Two exemplary pathways were confirmed in the
human colon cancer cell line HCT-116. In this cell line UPF reduced colony formation, induced a slow
G1 arrest and significant amounts of DNA damage, which was not observed in non-immortalized
primary human dermal fibroblasts.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/17/1/54/s1,
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